WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference

* Reuters is not responsible for the content in this press release.

Tue Jun 16, 2009 8:00am EDT 

SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE:
WX) today announced that Edward Hu, the Company's Chief Operating Officer and
acting Chief Financial Officer, will present at the Third Annual Jefferies
Healthcare Conference in New York on Wednesday, June 17, 2009, at 11:45 am
Eastern Daylight Savings Time.
    (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
    The Company will broadcast its presentation. The public may access the
broadcast through the Investor Relations section of the Company's web site:
http://www.wuxiapptec.com .
    About WuXi PharmaTech
    WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical
device R&D outsourcing company, with operations in China and the United
States.
As a research-driven and customer-focused company, WuXi PharmaTech provides a
broad and integrated portfolio of laboratory and manufacturing services
throughout the drug and medical device R&D process. WuXi PharmaTech's services
are designed to assist its global partners in shortening the cycle and
lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating
subsidiaries are known as WuXi AppTec. For more information, please visit:
http://www.wuxiapptec.com .
    For more information, please contact:

     Ronald Aldridge
     Director of Investor Relations
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +1-201-585-2048
     Email: Ron_Aldridge@wuxiapptec.com

     Web: http://www.wuxiapptec.com

SOURCE  WuXi PharmaTech (Cayman) Inc.

Ronald Aldridge, Director of Investor Relations of WuXi PharmaTech (Cayman)
Inc., +1-201-585-2048, or Ron_Aldridge@wuxiapptec.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.